Hydrocortisone is a topical steroid eye medication that helps reduce inflammation and irritation in the eye socket of patients who wear ocular prostheses (artificial eyes). It works by suppressing the immune system’s response that causes inflammation and excess secretions.

Dexamethasone is also a topical steroid eye medication that reduces inflammation and irritation. It is generally considered more potent than hydrocortisone and is commonly used to treat various eye conditions involving inflammation.

Dulcilarmes is an artificial tear solution that helps lubricate the eye socket and prosthesis. It acts as a tear substitute to provide moisture and comfort for patients with ocular prostheses. In this trial, it serves as a comparison treatment to evaluate the effectiveness of the steroid medications.

Conjunctivitis – A condition where the conjunctiva, the clear tissue covering the white part of the eye and inner eyelid, becomes inflamed and produces excessive secretions. The inflammation causes the eyes to become red, swollen, and produces varying amounts of discharge that can range from watery to thick. The secretions can vary in color and consistency, affecting the comfort of the eye and potentially interfering with vision. In cases involving eye prostheses, the condition can cause particular discomfort and requires special attention to the socket area.

Inflammatory Eye Disease – A condition characterized by inflammation of various parts of the eye tissue, particularly affecting the conjunctiva and surrounding areas. The condition typically manifests with increased secretion production, redness, and discomfort in the affected area. The inflammatory process can lead to changes in the quantity and quality of eye secretions, ranging from thin and watery to thick and viscous. This condition can particularly affect individuals with prosthetic eyes, causing specific challenges in the prosthesis-bearing socket.